Genitourinary Drugs Market was valued at US$ 35.78 Bn. in 2022. Genitourinary Drugs Market size is expected to grow at a CAGR of 2.25 % through the forecast period.
Large numbers of patients suffer from a variety of diseases in the genitourinary system, which is composed of kidneys, ureters, bladder, urethra, and genital organs. Genitourinary diseases include congenital abnormalities, iatrogenic injuries, and disorders such as cancer, trauma, infection, and inflammation.